semaglutide and anorexia Researchers found that 32% of patients with eating disorders report having used a weight loss injection at least once, according to a study in JAMA Psychiatry released on Wednesday. Experts worry the GLP-1 RAs in Eating Disorders:

CD28 costimulation triggers the PI3K/Akt axis in T cells, inducing GLUT1 expression, which enhances glucose uptake and utilization

I have already booked my next appointment

Headaches are also relatively common

| BioPharma Dive, accessed February 2, 2026, Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices | AJMC, accessed February 2, 2026, Federal Update: Trump Administration Announces Deal to Bring Most-Favored-Nation Pricing to GLP-1s AMCP, accessed February 2, 2026, Eli Lilly, Novo Nordisk strike deals with White House to cut prices of weight loss drugs, accessed February 2, 2026, The GLP-1 Blockbuster Maker Widens Its Lead as the Diversified Healthcare Giant Posts Steady Growth, accessed February 2, 2026, Eli Lilly Stock Outlook: Fast-Track Oral GLP-1 Review Meets Long-Term Catalysts, accessed February 2, 2026, Beyond the Needle: Eli Lillys Orforglipron and the Small Molecule GLP-1 Revolution, accessed February 2, 2026, Patent and Innovation Trends in GLP-1 and Weight Loss Drugs (20202025): What the IP and Science Signal Next | Cypris, accessed February 2, 2026,

Dietitians help you build a structured, nutrientdense, lowervolume eating pattern that fits your appetite, culture, budget and health conditions, rather than leaving you to live on dry crackers and hope for the best, and organisations experienced in GLP1 care, such as Ausclin, integrate this support into routine consultations